Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001628280-25-034531

Chief Financial Officer sold 14,827 shares at $4.26 ($63,163)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kelly John Alexander Chief Financial Officer 2025-07-03 Sale 10b5-1 −14,827 $4.26 $63,163 73,485 D: show line 1 in the form
Open-market sales · 14,827 sh · avg $4.26 · $63,163
Loading xslF345X05/wk-form4_1752006603.xml…